Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Clinical trial NCT03380377 · COMPLETED

Trial details

NCT number: NCT03380377
Sponsor: Stanley Jordan, MD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Antibody-mediated Rejection Kidney Transplant; Complications Transplant Glomerulopathy Transplant Glomerulopathy - Late Form Transplant Glomerulopathy - Early Form Kidney Transplant Rejection

Start date: 2018-02-21
Primary completion: 2024-04-16
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.